These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 20702390)

  • 1. Prescribing in a pandemic: best use of oseltamivir in paediatric intensive care.
    Seale AC; Toussaint FS; Finn A; Fraser JI
    Arch Dis Child; 2011 Sep; 96(9):902-3. PubMed ID: 20702390
    [No Abstract]   [Full Text] [Related]  

  • 2. Antiviral agents: to treat or not to treat? An old dilemma revisited in light of new data from the 2009 influenza A(H1N1) pandemic.
    Hernández JM; López-Rodas V; Costas E
    J Clin Virol; 2010 Oct; 49(2):145-6. PubMed ID: 20674477
    [No Abstract]   [Full Text] [Related]  

  • 3. Rapid increase in use of antiviral therapy for hospitalized children with influenza during the 2009 H1N1 epidemic.
    Hersh AL; Herigon JC; Ampofo K; Pavia AT; Newland JG
    Pediatr Infect Dis J; 2011 Oct; 30(10):895-7. PubMed ID: 21587093
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influenza a (H1N1) virus pneumonia in newborns: experience of a referral level III neonatal intensive care unit in Turkey.
    Kanmaz G; Erdeve O; Oguz SS; Uras N; Dilmen U
    Pediatr Pulmonol; 2011 Feb; 46(2):201-2; author reply 203. PubMed ID: 20963837
    [No Abstract]   [Full Text] [Related]  

  • 5. Reduced effectiveness of oseltamivir in children infected with oseltamivir-resistant influenza A (H1N1) viruses with His275Tyr mutation.
    Saito R; Sato I; Suzuki Y; Baranovich T; Matsuda R; Ishitani N; Dapat C; Dapat IC; Zaraket H; Oguma T; Suzuki H
    Pediatr Infect Dis J; 2010 Oct; 29(10):898-904. PubMed ID: 20442686
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influenza antiviral prescribing practices during the 2007-08 and 2008-09 influenza seasons in the setting of increased resistance to oseltamivir among circulating influenza viruses.
    Dharan NJ; Beekmann SE; Fiore A; Finelli L; Uyeki TM; Polgreen PM; Fry AM
    Antiviral Res; 2010 Nov; 88(2):182-6. PubMed ID: 20739002
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FDA notifications. EUA issued for treating novel 2009 H1N1 flu.
    AIDS Alert; 2009 Jun; 24(6):69-70. PubMed ID: 19544608
    [No Abstract]   [Full Text] [Related]  

  • 8. Do immunosupressive patients really have a severe outcome with H1N1 virus infection?
    Akyüz S; Yilmaz A; Bülbül M; Erdogan O; Renda R; Demircin G
    J Trop Pediatr; 2011 Apr; 57(2):129-31. PubMed ID: 20587734
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oseltamivir-induced resistant pandemic A/H1N1 influenza virus in a child with cystic fibrosis and Pseudomonas aeruginosa infection.
    Esposito S; Molteni CG; Colombo C; Daleno C; Daccò V; Lackenby A; Principi N
    J Clin Virol; 2010 May; 48(1):62-5. PubMed ID: 20335065
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hemophagocytic lymphohistiocytosis associated with 2009 pandemic influenza A (H1N1) virus infection.
    Ozdemir H; Çiftçi E; Ince EU; Ertem M; Ince E; Doğru U
    J Pediatr Hematol Oncol; 2011 Mar; 33(2):135-7. PubMed ID: 21285906
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 2009 Influenza A H1N1 infections: delays in starting treatment with oseltamivir were associated with a more severe disease.
    Launes C; García-García JJ; Jordán I; Martínez-Planas A; Selva L; Muñoz-Almagro C
    Pediatr Infect Dis J; 2011 Jul; 30(7):622-5. PubMed ID: 21200359
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Degree of adherence to recommended antiviral treatment during the pandemic and post-pandemic periods of influenza A(H1N1)pdm09 in 148 intensive care units in Spain.
    Canadell L; Martín-Loeches I; Díaz E; Trefler S; Grau S; Yebenes JC; Almirall J; Olona M; Sureda F; Blanquer J; Rodriguez A;
    Med Intensiva; 2015 May; 39(4):222-33. PubMed ID: 25107582
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recovery of a multidrug-resistant strain of pandemic influenza A 2009 (H1N1) virus carrying a dual H275Y/I223R mutation from a child after prolonged treatment with oseltamivir.
    Nguyen HT; Fry AM; Loveless PA; Klimov AI; Gubareva LV
    Clin Infect Dis; 2010 Oct; 51(8):983-4. PubMed ID: 20858074
    [No Abstract]   [Full Text] [Related]  

  • 14. Rising Oseltamivir Use Among Hospitalized Children in a Postpandemic Era.
    Williams JT; Cunningham MA; Wilson KM; Rao S
    Hosp Pediatr; 2016 Mar; 6(3):172-8. PubMed ID: 26908818
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety profile of oseltamivir during the 2009 influenza pandemic.
    Donner B; Bader-Weder S; Schwarz R; Peng MM; Smith JR; Niranjan V
    Pharmacoepidemiol Drug Saf; 2011 May; 20(5):532-43. PubMed ID: 21448900
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pandemic (H1N1) 2009 infection in adult solid organ transplant recipients in Singapore.
    Low CY; Kee T; Chan KP; Oon LL; Tan CK; Tee NW; Tan BH
    Transplantation; 2010 Nov; 90(9):1016-21. PubMed ID: 20814355
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aseptic meningitis in a child due to 2009 pandemic influenza A (H1N1) infection.
    Ozdemir H; Karbuz A; Ciftçi E; Ince E; Doğru U
    Turk J Pediatr; 2011; 53(1):91-3. PubMed ID: 21534347
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A descriptive study of oseltamivir-treated hospitalised patients].
    Moreno Parrado L; Sola-Morena MD; Pagán Nuñez FT; Hernández Sansalvador M; Simarro Córdoba E; García-Martínez EM
    Farm Hosp; 2011; 35(4):220-2. PubMed ID: 21641258
    [No Abstract]   [Full Text] [Related]  

  • 19. The use of antiviral agents for the management of severe influenza.
    Smith JR; Ariano RE; Toovey S
    Crit Care Med; 2010 Apr; 38(4 Suppl):e43-51. PubMed ID: 19935416
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Oseltamivir-resistant influenza A pandemic (H1N1) 2009 virus].
    Boibieux A
    Ann Fr Anesth Reanim; 2010 Feb; 29(2):85-6. PubMed ID: 20167451
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.